Last reviewed · How we verify

NCT04660214

Minimally Invasive Endoscopic Treatment of Zenker's Diverticulum Comparing LigaSureTM vs SB-Knife.

Recruiting now NA Last updated 23 February 2024
What this trial tests

NA trial testing septotomy in Zenker Diverticulum in 80 participants. Currently enrolling.

Timeline
28 June 2021
Primary endpoint
30 June 2024
31 December 2026

Quick facts

Lead sponsorHospital del Rio Hortega
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date28 June 2021
Primary completion30 June 2024
Estimated completion31 December 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital del Rio Hortega

Who can join

Adults 18 to 110, any sex, with Zenker Diverticulum or Minimally Invasive Surgical Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this trial is to evaluate two devices used in the treatment of Zenker Diverticulum using flexible endoscopy (LigaSure and SB-knife). Analyze the technical success, clinical success, relapses, complications, and the mean procedure time with each device prospectively in order to transfer objective and uniform results to routine clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Zenker Diverticulum

Currently open trials in the same condition.

Other Hospital del Rio Hortega trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660214.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing